Private equity buyers eye offer for GlaxoSmithKline's drinks brands

Private equity firms Blackstone and Lion Capital are together eyeing an offer for GlaxoSmithKline's ($GSK) drinks brands Lucozade and Ribena. Up for sale as the U.K.-based drugmaker sheds lower-performing and non-core assets, the brands could fetch a bid worth more than £1 billion. Report